A physiological basis for the treatment of essential hypertension.
作者信息
Weber M A, Laragh J H
出版信息
Bull N Y Acad Med. 1978 Nov;54(10):931-43.
Abstract
摘要
相似文献
1
A physiological basis for the treatment of essential hypertension.
Bull N Y Acad Med. 1978 Nov;54(10):931-43.
2
[Essential hypertension: Renin and aldosterone, key to pathogeny and therapy?].[原发性高血压：肾素与醛固酮，发病机制及治疗的关键？]
Schweiz Med Wochenschr. 1974 Jul 20;104(29):1013-22.
3
The renin-angiotensin system in hypertension.高血压中的肾素-血管紧张素系统。
J Maine Med Assoc. 1977 Nov;68(11):413-6.
4
The effects of clonidine and propranolol, separately and in combination, on blood pressure and plasma renin activity in essential hypertension.可乐定和普萘洛尔单独及联合应用对原发性高血压患者血压和血浆肾素活性的影响。
J Clin Pharmacol. 1978 May-Jun;18(5-6):233-40. doi: 10.1002/j.1552-4604.1978.tb02441.x.
5
[The adrenergic system and the control of the renin and aldosterone circadian rhythm in essential arterial hypertension].[肾上腺素能系统与原发性高血压中肾素和醛固酮昼夜节律的调控]
Boll Soc Ital Biol Sper. 1977 Oct 30;53(20):1762-6.
6
Hypertension: selection of treatment in relation to the mechanisms raising blood pressure.高血压：根据血压升高机制选择治疗方法。
Brux Med. 1973 Nov;Spec No(0):87-98.
7
8
Propranolol, renin and hypertension: a review.普萘洛尔、肾素与高血压：综述
Postgrad Med J. 1976;52 Suppl 4(604):109-15.
9
[Renin and aldosterone in human arterial hypertension (excluding Conn's syndrome)].[人类动脉高血压中的肾素和醛固酮（不包括原发性醛固酮增多症）]
Pathol Biol. 1965 Nov;13(21):1086-93.
10
[Hemodynamic and hormonologic basis of the treatment of arterial hypertension].[动脉高血压治疗的血流动力学和激素学基础]
Arch Mal Coeur Vaiss. 1974 Oct;67(10):1145-55.
本文引用的文献
1
The meaning of aldosteronism in hypertensive disease.
Circ Res. 1967 Jul;21(1):Suppl 2:177+.
2
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases.普萘洛尔对肾素分泌的抑制作用。一种诊断和治疗肾素依赖性高血压疾病的特定方法。
N Engl J Med. 1972 Dec 14;287(24):1209-14. doi: 10.1056/NEJM197212142872401.
3
The syndrome of essential hypertension and suppressed plasma renin activity. Normalization of blood pressure with spironolactone.
Arch Intern Med. 1972 Dec;130(6):849-54.
4
Hyporeninemic hypertension.低肾素性高血压
Am J Med. 1972 Apr;52(4):457-66. doi: 10.1016/0002-9343(72)90036-8.
5
6
Volume factor in low and normal renin essential hypertension. Treatment with either spironolactone or chlorthalidone.低肾素型和正常肾素型原发性高血压的容量因素。用螺内酯或氢氯噻嗪治疗。
Am J Cardiol. 1973 Sep 20;32(4):523-32. doi: 10.1016/s0002-9149(73)80044-x.
7
Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.普萘洛尔的降压作用。原发性、肾性、肾血管性和恶性高血压的高肾素型和正常肾素型中的特异性抗肾素反应。
Am J Cardiol. 1973 Sep 20;32(4):511-22. doi: 10.1016/s0002-9149(73)80043-8.
8
Side effects of hypotensive agents evaluated by a self-administered questionnaire.通过自行填写问卷评估降压药的副作用。
Br Med J. 1973 Sep 1;3(5878):485-90. doi: 10.1136/bmj.3.5878.485.
9
Vasodilator drugs in the treatment of hypertension.
Arch Intern Med. 1974 Jun;133(6):1017-27.
10
Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles.用于理解和治疗高血压的血管收缩-容量分析：肾素和醛固酮谱的应用
Am J Med. 1973 Sep;55(3):261-74. doi: 10.1016/0002-9343(73)90128-9.
Zotero 插件